Patents by Inventor Li Fu

Li Fu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12277428
    Abstract: A display device control method includes when an operation on an on-screen display (OSD) input device is received, determining whether a signal generated by operating the OSD input device is currently sent to an OSD system or an operating system (OS); and when the signal generated by operating the OSD input device is currently sent to the OS, switching, according to a control signal generated by the OSD input device, the control signal from being sent to the OSD system to being sent to the OS. This application further provides a display device.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: April 15, 2025
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Wei Zhu, Xingyang Sun, Li Fu, Qinghai Liang, Chiahsing Chung
  • Publication number: 20250114628
    Abstract: The photobiomodulation apparatus (and method of use) of the present invention comprises one or more light sources which are integrated into a transparent flexible mouthpiece housing containing a semi rigid support member for providing photobiomodulation therapy to the oral mucosa of a cancer patient suffering from, or at risk of, Oral Mucositis. The light sources can be either internal, or external to the transparent flexible mouthpiece housing, and either lasers, light emitting diodes (LEDs), lamps, or any other types of light sources which produce therapeutic light in a desired wavelength range. The therapeutic light is delivered through the transparent flexible mouthpiece housing to the oral mucosa. The delivered light produces a photochemical and photophysical process e.g. increase the blood flow and circulation. This photochemical and photophysical process helps to reduce the incidence and severity of oral mucositis in cancer patients and helps improve outcomes of cancer therapy.
    Type: Application
    Filed: September 17, 2024
    Publication date: April 10, 2025
    Applicant: SBR Biotechnologies, Inc.
    Inventors: Ross Lefkowitz, Brian Pryor, Sean Xiaolu Wang, Dan Liu, Li Fu
  • Patent number: 12224422
    Abstract: A solventless method of making a dry electrode for an electrochemical cell is provided. A solventless electrode material mixture includes 85-99% electrode active material and from 0-10% conductive carbon additive. A polymer binder system is present from 1-15%. The polymer binder system includes one or more polymer binders. The electrode material mixture is mixed at a temperature greater than a softening point or a melting point of at least one polymer binder of the polymer binder system. The electrode material mixture is kneaded into an electrode material dough. The electrode material dough is formed into an electrode material sheet. At least a portion of the electrode material sheet is affixed to a metal current collector to form an electrode.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: February 11, 2025
    Assignee: Nano and Advanced Materials Institute Limited
    Inventors: Soon Yee Liew, Yong Zhu, Yam Chong, Yu Tat Tse, Kevin Tan, Shengbo Lu, Li Fu, Chenmin Liu
  • Patent number: 12217739
    Abstract: A speech recognition method, including acquiring first linear frequency spectrums corresponding to audios to be trained with different sampling rates; determining the maximum sampling rate and other sampling rates; determining the maximum frequency domain sequence number of the first linear frequency spectrums as a first frequency domain sequence number and a second frequency domain sequence number; in the first linear frequency spectrums corresponding to the other sampling rate, configuring amplitude values corresponding to each frequency domain sequence number that is greater than the first frequency domain sequence number and less than or equal to the second frequency domain sequence number to be zero to obtain second linear frequency spectrums; determining first speech features and second voice features; and using the first speech features and the second speech features to train a machine learning model.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: February 4, 2025
    Assignee: JINGDONG TECHNOLOGY HOLDING CO., LTD.
    Inventor: Li Fu
  • Publication number: 20240366644
    Abstract: The present invention discloses a novel application of ginsenoside Rd in preparation of a drug for relieving or/and treating inflammations and health food/medicinal and edible food/functional food/dietary supplement. Tests prove that ginsenoside Rd has a remarkable curative effect on inflammations, takes effect quickly, has a better effect than Dexamethasone, is suitable for both acute inflammations such as influenza virus pneumonia, novel coronavirus pneumonia and acute lung injury inflammations, and chronic inflammations such as chronic obstructive pneumonia and chronic asthmatic airway inflammations, and is regarded as a new drug source for treating acute and chronic inflammations and complications thereof.
    Type: Application
    Filed: July 10, 2024
    Publication date: November 7, 2024
    Inventor: Li FU
  • Patent number: 12094469
    Abstract: A method for recognizing speech comprises: respectively setting initial values of a Chinese character coefficient and a Pinyin coefficient, generating a Chinese character mapping function according to the initial value of the Chinese character coefficient, and generating a Pinyin mapping function according to the initial value of the Pinyin coefficient (S101); training the Chinese character mapping function and the Pinyin mapping function using a plurality of preset training samples, calculating training results as parameters of a joint loss function, and generating a target mapping function according to calculation results (S102); and recognizing, according to the target mapping function, speech to be recognized, so as to obtain a Chinese character recognition result and a Pinyin recognition result of the speech to be recognized (S103). The method reduces the cost of speech recognition while ensuring the accuracy of speech recognition.
    Type: Grant
    Filed: March 3, 2020
    Date of Patent: September 17, 2024
    Assignee: JINGDONG TECHNOLOGY HOLDING CO., LTD.
    Inventors: Li Fu, Xiaoxiao Li
  • Publication number: 20240304860
    Abstract: A quasi-solid-state battery formed from non-gas evolving in-situ curing of a quasi-solid-state electrolyte that includes a high swelling polymer made from a monomer with good compatibility with liquid electrolytes, and has a good reactivity for facile non-gas evolving in-situ polymerization. The monomer can be based on acrylate polymerization chemistry or an allyl group polymerization chemistry. Non-gas evolving initiators are used for non-gas evolving in-situ polymerization of acrylate or allyl monomer-based QSE. The resulting QSE additionally has high ionic conductivity, allowing for a high battery output, and a wide electrochemical window (stable for lithium metal anode and high-voltage cathodes). The resulting quasi solid electrolyte battery is not only easy to fabricate using conventional battery manufacturing practices, the non-gas evolving in-situ polymerization causes the QSE to be uniformly distributed within the battery, ensuring high-quality, safe battery performance and longevity.
    Type: Application
    Filed: March 5, 2024
    Publication date: September 12, 2024
    Inventors: Soon Yee LIEW, Ho Mei LAW, Fei ZHANG, Yu Tat TSE, Shengbo LU, Li FU, Yong ZHU, Chenmin LIU, Yan Lung WONG
  • Publication number: 20240264474
    Abstract: Disclosed are an optical waveguide device and manufacturing method thereof. The optical waveguide device includes a substrate and an optical modulation module electrically connected with the substrate, the optical modulation module including: an underlay having a first surface relatively close to the substrate and a second surface relatively far away from the substrate, which are provided opposite to each other; an optical waveguide lamination, located between the first surface of the underlay and the substrate, including a lower cladding layer, an optical waveguide layer and an upper cladding layer located between the first surface of the underlay and the optical waveguide layer, which are three stacked in a first direction perpendicular to a plane where the underlay is located; and a conductive structure, located between the optical waveguide layer and the substrate and electrically connected with the optical waveguide layer to conduct an electric signal to the optical waveguide layer.
    Type: Application
    Filed: August 6, 2021
    Publication date: August 8, 2024
    Applicant: Accelink Technologies Co., Ltd.
    Inventors: Xuerui LIANG, Qianchen YU, Li FU, Bo ZHANG, Yi HU, Yong LUO, Qianggao HU
  • Publication number: 20240233708
    Abstract: Disclosed in the present disclosure are a method and apparatus for generating a speech recognition training set. The method may include: acquiring a to-be-processed audio and a to-be-processed video, where the to-be-processed video comprises text information corresponding to the to-be-processed audio; recognizing the to-be-processed audio to obtain an audio text; recognizing text information in the to-be-processed video to obtain a video text; and using, based on consistency of the audio text with the video text, the to-be-processed audio as a speech sample and the video text as a label to obtain the speech recognition training set.
    Type: Application
    Filed: April 15, 2022
    Publication date: July 11, 2024
    Inventor: Li FU
  • Publication number: 20230385084
    Abstract: A display device control method includes when an operation on an on-screen display (OSD) input device is received, determining whether a signal generated by operating the OSD input device is currently sent to an OSD system or an operating system (OS); and when the signal generated by operating the OSD input device is currently sent to the OS-system, switching, according to a control signal generated by the OSD input device, the control signal from being sent to the OSD system to being sent to the OS-system. This application further provides a display device.
    Type: Application
    Filed: September 8, 2021
    Publication date: November 30, 2023
    Inventors: Wei Zhu, Xingyang Sun, Li Fu, Qinghai Liang, Chiahsing Chung
  • Publication number: 20230380609
    Abstract: Provided herein is a reactive pillow comprising: a pressure sensor mat (11) including a first electrode fabric layer (20) having a plurality of first conductive portions (13) and a plurality of first non-conductive portions; a second electrode fabric layer (21) having a plurality of second conductive portions (14) and a plurality of second non-conductive portions; and a piezoresistive fabric layer (24) having a sheet resistance of at least 50K ohm/square; an actuator (40) comprising a plurality of first airbags (41, 42, 43) and a second airbag (44), each of the airbags (41, 42, 43, 44) having an inflated configuration corresponding to an increase in the volume of the airbags (41, 42, 43, 44) and a deflated configuration corresponding to a decrease in the volume of the airbags (41, 42, 43, 44); a controller communicating with the pressure sensor mat (11) and the actuator (40) communicating with the controller to actuate the controller to convert the airbags (41, 42, 43, 44) between the inflated configuration a
    Type: Application
    Filed: October 8, 2021
    Publication date: November 30, 2023
    Inventors: Li FU, Yam CHONG, Chun Wah CHU, Chenmin LIU
  • Publication number: 20230338454
    Abstract: In one aspect, the present invention discloses a composition of forsythia suspensa component and an optional panax ginseng component that can be used safely, efficiently and consistently to achieve antiviral, antipyretic, anti-inflammatory and/or immunity boosting effects, including forsythin, forsythin derivatives, and the composition of forsythin and phillygenin for the prevention and treatment of diseases associated with human cytomegalovirus infection, such as simple human cytomegalovirus infection or for patients infected by human cytomegalovirus during prevention and treatment of cardiovascular and cerebrovascular diseases, tumors, bums or AIDS or during a process of organ transplantation or during the perinatal period. In another aspect, this application provides a process for preparing the composition of forsythia suspensa and panax ginseng components is simple, suitable for industrial production and easy to popularize.
    Type: Application
    Filed: August 31, 2021
    Publication date: October 26, 2023
    Inventors: Shuo WANG, Li FU, Xue FENG, Yang LIU, Rongxin LIN, Jirui HOU, Mingming LU, Wenfei FU, Qi LU, Qingfeng ZHOU
  • Patent number: 11796401
    Abstract: A pressure distribution mapping system includes a flexible M×N textile-based pressure sensor array. with first and second electrode textile layers and a piezoresistive fabric layer with a sheet resistance of at least 60 k-ohm/square positioned between the first and second electrode textile layers. Individual pressure sensors are formed by an intersection between a row electrically-conductive path and a column electrically-conductive path along with the portion of the piezoresistive layer positioned at the intersection. A measurement system measures the resistance of each pressure sensor of the pressure sensor array. The measurement system includes a reading module with first op-amps connected to each row and second op-amps connected to each column.
    Type: Grant
    Filed: April 6, 2022
    Date of Patent: October 24, 2023
    Assignee: Nano and Advanced Materials Institute Limited
    Inventors: Yam Chong, Tao Xu, Li Fu, Chenmin Liu
  • Publication number: 20230321125
    Abstract: In one aspect, a composition of ginsenoside Rg3 and ginsenoside Rg5 and a preparation method thereof, as well as its application in manufacturing drugs, foods and health products for boosting immunity, enhancing anti-tumor effects, improving resistance to anti-tumor targeted drugs, mitigating toxic and side effects of radiotherapy and chemotherapy or improving anti-fatigue effects. The composition has advantages in rapid action, less toxicity and side effects and is suitable for long-term use. In another aspect, a safe, highly efficient and stable drug, food or health product which can be obtained by a simple preparation process suitable for industrial production and which can be easily scaled up.
    Type: Application
    Filed: August 20, 2021
    Publication date: October 12, 2023
    Inventors: Shou WANG, Li FU, Yang LIU, Mingming LU, Rongxin LIN, Wenfei FU, Xue FENG
  • Publication number: 20230321137
    Abstract: A method of manufacturing a high molecular weight heparin (HMWH) compound is disclosed. The method comprises dissolving heparin to form a heparin solution and fractionating the heparin solution via tangential flow filtration (TFF) using a membrane with a molecular weight cut off (MWCO) between about 8 kDa and about 12 kDa. The TFF yields a retentate comprising fractionated heparin with a weight average molecular weight of about 20 kDa or greater, i.e., a high molecular weight heparin compound. A substantial proportion of heparin chains in the fractionated heparin may have a high molecular weight, e.g., 50% of the heparin chains or greater may have a molecular weight of 20 kDa or greater.
    Type: Application
    Filed: June 12, 2023
    Publication date: October 12, 2023
    Applicant: NexEos Diagnostics, Inc.
    Inventors: Li FU, Zhenyu WANG, Jessica PAX
  • Patent number: 11740143
    Abstract: The present disclosure provides a flexible pressure sensor array and method for fabricating the same. The pressure sensor array comprises a pressure-sensing substrate, top electrodes and bottom electrodes. The pressure-sensing substrate comprises a piezoresistive material, a fabric and pressure-sensing columns. The top electrodes and the bottom electrodes are attached to the pressure-sensing columns. The pressure sensor array is ultra-flexible and conforms to 3-dimensional surface for pressure monitoring.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: August 29, 2023
    Assignee: Nano and Advanced Materials Institute Limited
    Inventors: Li Fu, Tao Xu, Yam Chong
  • Patent number: 11712447
    Abstract: A method of manufacturing a high molecular weight heparin (HMWH) compound is disclosed. The method comprises dissolving heparin to form a heparin solution and fractionating the heparin solution via tangential flow filtration (TFF) using a membrane with a molecular weight cut off (MWCO) between about 8 kDa and about 12 kDa. The TFF yields a retentate comprising fractionated heparin with a weight average molecular weight of about 20 kDa or greater, i.e., a high molecular weight heparin compound. A substantial proportion of heparin chains in the fractionated heparin may have a high molecular weight, e.g., 50% of the heparin chains or greater may have a molecular weight of 20 kDa or greater.
    Type: Grant
    Filed: May 12, 2022
    Date of Patent: August 1, 2023
    Assignee: NexEos Diagnostics, Inc.
    Inventors: Li Fu, Zhenyu Wang, Jessica Pax
  • Publication number: 20230230950
    Abstract: A self-densifying interconnection is formed between a high-temperature semiconductor device selected from a GaN or SiC-based device and a substrate. The interconnection includes a matrix of micron-sized silver particles in an amount from approximately 10 to 60 weight percent; the micron-sized silver particles having a particle size ranging from approximately 0.1 microns to 15 microns. Bonding particles are used to chemically bind the matrix of micron-sized silver particles. The bonding particles are core silver nanoparticles with in-situ formed surface silver nanoparticles chemically bound to the surface of the core silver nanoparticles and, at the same time, chemically bound to the matrix of micron-sized silver particles. The bonding particles have a core particle size ranging from approximately 10 to approximately 100 nanometers while the in-situ formed surface silver nanoparticles have a particle size of approximately 3-9 nanometers.
    Type: Application
    Filed: January 12, 2023
    Publication date: July 20, 2023
    Inventors: Yuechen WANG, Tao XU, Li FU
  • Publication number: 20230151400
    Abstract: The present disclosure relates to synthesis of heparin, which may be bioequivalent to porcine USP Heparin Sodium. The synthesis may involve three intermediates starting from heparosan.
    Type: Application
    Filed: January 20, 2023
    Publication date: May 18, 2023
    Applicant: Rensselaer Polytechnic Institute
    Inventors: Marc DOUAISI, Navdeep GROVER, Payel DATTA, Elena PASKALEVA, Lei LIN, Paul BRODFUEHRER, Trevor J. SIMMONS, Akihiro ONISHI, Makoto HIRAKANE, Li FU, Kevin LI, Robert J. LINHARDT, Jonathan DORDICK, Daisuke MORI
  • Publication number: 20230101803
    Abstract: The present invention provides a use of a phillyrin/phillygenin composition which targets and inhibits 3CLpro protein of COVID-19 virus, in preparation of an anti-coronavirus drug or a drug for treating a disease caused by the coronavirus, wherein the coronavirus is COVID-19 virus, and the disease caused by the coronavirus is COVID-19.
    Type: Application
    Filed: February 9, 2021
    Publication date: March 30, 2023
    Inventors: Zifeng YANG, Li FU, Ge JIANG, Nanshan ZHONG, Wei YANG, Qinhai MA, Min HUI, Chufang LI, Shuo WANG, Weiyi PAN, Qi LU, Aiai SONG, Jirui HOU, Runfeng LI, Mingming LU, Yingping WANG, Yang LIU, Guoyou LIU, Wenfei FU, Xue FENG, Qingfeng ZHOU, Xiaofeng YI, Rongxin LIN, Yu ZHANG